Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol.
BMJ Open
; 10(12): e040580, 2020 Dec 02.
Article
in En
| MEDLINE
| ID: mdl-33268419
Full text:
1
Database:
MEDLINE
Main subject:
Zinc
/
COVID-19 Drug Treatment
Type of study:
Clinical_trials
/
Guideline
Language:
En
Journal:
BMJ Open
Year:
2020
Type:
Article
Affiliation country:
Australia